Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,136 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Outcomes of persistently active neovascular age-related macular degeneration treated with VEGF inhibitors: observational study data.
Barthelmes D, Walton R, Campain AE, Simpson JM, Arnold JJ, McAllister IL, Guymer RH, Hunyor AP, Essex RW, Morlet N, Gillies MC; Fight Retinal Blindness! Project Investigators. Barthelmes D, et al. Among authors: walton r. Br J Ophthalmol. 2015 Mar;99(3):359-64. doi: 10.1136/bjophthalmol-2014-305514. Epub 2014 Sep 23. Br J Ophthalmol. 2015. PMID: 25249615 Free article.
Intravitreal therapy in bilateral neovascular age-related macular degeneration.
Barthelmes D, Walton RJ, Arnold JJ, McAllister IL, Simpson JM, Campain A, Hunyor AP, Guymer R, Essex RW, Morlet N, Gillies MC; Fight Retinal Blindness! Project Investigators. Barthelmes D, et al. Among authors: walton rj. Ophthalmology. 2014 Oct;121(10):2073-4. doi: 10.1016/j.ophtha.2014.05.007. Epub 2014 Jun 14. Ophthalmology. 2014. PMID: 24939512 Free article. No abstract available.
Prospective audit of exudative age-related macular degeneration: 12-month outcomes in treatment-naive eyes.
Gillies MC, Walton R, Simpson JM, Arnold JJ, Guymer RH, McAllister IL, Hunyor AP, Essex RW, Morlet N, Barthelmes D; Fight Retinal Blindness! Project Investigators. Gillies MC, et al. Among authors: walton r. Invest Ophthalmol Vis Sci. 2013 Aug 27;54(8):5754-60. doi: 10.1167/iovs.13-11993. Invest Ophthalmol Vis Sci. 2013. PMID: 23821201 Free article.
Reporting of harms by randomised controlled trials in ophthalmology.
O'Day R, Walton R, Blennerhassett R, Gillies MC, Barthelmes D. O'Day R, et al. Among authors: walton r. Br J Ophthalmol. 2014 Aug;98(8):1003-8. doi: 10.1136/bjophthalmol-2013-304687. Epub 2014 Feb 10. Br J Ophthalmol. 2014. PMID: 24515989 Review.
Time to initial clinician-reported inactivation of neovascular age-related macular degeneration treated primarily with ranibizumab.
Gillies MC, Campain A, Walton R, Simpson JM, Arnold JJ, Guymer RH, McAllister IL, Hunyor AP, Essex RW, Morlet N, Barthelmes D; Fight Retinal Blindness Study Group. Gillies MC, et al. Among authors: walton r. Ophthalmology. 2015 Mar;122(3):589-594.e1. doi: 10.1016/j.ophtha.2014.10.001. Epub 2014 Nov 6. Ophthalmology. 2015. PMID: 25458197
1,136 results